<DOC>
	<DOCNO>NCT00906321</DOCNO>
	<brief_summary>Background : - Chemoprevention use preventive medication reduce risk breast cancer woman high risk develop disease . Although treatment show effectiveness prevent cancer development , chemoprevention notably underutilized even woman high risk develop breast cancer . - Researchers interested determine good decision support mechanism , interactive Web site , help overcome barrier chemoprevention . Objectives : - To develop test prototype Web-based module provide decision support woman consider chemoprevention breast cancer . Eligibility : - Women 35 year age old high risk breast cancer whose doctor recommend chemoprevention ( either Tamoxifen Raloxifene ) , history cancer ( apart non-melanoma skin cancer precancerous cervical lesion ) . - Participants must work e-mail address access computer internet access telephone . Design : - Participants consider chemoprevention randomize Web-based decision support module standard care online information resource . - Participation last two month involve use online resource provide fill questionnaire two time study ( begin end ) . The first time begin study . - No medical treatment offer part study</brief_summary>
	<brief_title>Facilitating Web-based Patient Decision Support : Decision About Medication Lower Breast Cancer Risk</brief_title>
	<detailed_description>BACKGROUND : - Breast cancer chemoprevention notably underutilized . - Barriers integrate breast cancer risk reduce measure include : lack time , low priority risk reduction comparison treatment , need personalize risk benefit chemoprevention , need resources/information necessary woman make informed decision . - Access quality decision support resource facilitate make inform , preference-sensitive decision chemoprevention may provide mechanism overcome current barrier chemoprevention utilization . OBJECTIVES : - Develop refine web-based patient decision support module high-risk woman make decision breast cancer chemoprevention . - Conduct randomize study TACHD decision support versus standard care online information support evaluate impact chemoprevention module TACHD decision support intervention . ELIGIBILITY : - Women history cancer cervical carcinoma situ non-melanoma skin cancer - High risk breast cancer base least one following : - Gail score &gt; 1.67 - History atypical hyperplasia ( either ductal lobular ) - History lobular carcinoma situ - Documentation deleterious BRCA1 BRCA2 mutation - Considering decision chemoprevention tamoxifen raloxifene - Access IBM-compatible MacIntosh personal computer broadband Internet access - Access email account - Access telephone - Aged 35 old - Able communicate English verbally write DESIGN : - The project guide Cognitive-Social Health Information Processing ( CSHIP ) model overall , incorporate Ottawa Decision Support . Framework ( ODSF ) one consistent decision support process . - Testing chemoprevention decision support module conduct two-group pre- post-test experimental design 64 at-risk woman identify Fox Chase Risk Assessment Programs NCI Clinical Cancer Genetics Program ( CCGP ) National Naval Medical Center ( NNMC ) . - A process evaluation analysis ass participant ' experience use TACHD .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>INCLUSION CRITERIA : 1 . Women history cancer cervical carcinoma situ nonmelanoma skin cancer 2 . High risk breast cancer base least one following : Gail score &gt; 1.67 History atypical hyperplasia ( either ductal lobular ) History lobular carcinoma situ Documentation deleterious BRCA1 BRCA2 mutation 3 . Considering decision chemoprevention tamoxifen raloxifene 4 . Access IBMcompatible MacIntosh personal computer broadband Internet access 5 . Access email account 6 . Access telephone 7 . Aged 35 old 8 . Able communicate English verbally write 9 . Women race ethnic group eligible study . EXCLUSION CRITERIA : 1 . Concurrent participation another cancer chemoprevention study 2 . Prior history cancer , cervical carcinoma situ nonmelanoma skin cancer 3 . Ever take tamoxifen raloxifene 4 . Age less 35 5 . Unable communicate English verbally write 6 . No computer internet access 7 . No email account 8 . No telephone</criteria>
	<gender>Female</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>May 26, 2010</verification_date>
	<keyword>Web-Based Decision Support</keyword>
	<keyword>Breast Cancer Risk</keyword>
</DOC>